Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
X
-
BGI will launch at least two new sequencers this year. We will start some early-access projects to benchmark the new sequencers soon.
-
The linked text is just a translation of the Genomeweb article I would guess. In there they discuss BGI:s "Million genomes" project, not 1 million genomes per year.
If I remember correctly, CG now uses an ordered flow cell with 6 billion clusters, one cluster per pixel. Aiming for cameras capable of 500 MP/s (?), not sure what that would translate to in terms of genomes / year. 100 bp reads with long fragment technology and higher quality than Illumina.
Leave a comment:
-
1,000,000 genomes per year? Kind of like the claim BGI had a few years ago about having 1000 bioinformaticians. Maybe someone got their powers of 10 off a couple of places.
Leave a comment:
-
ah.. I think I understand now. BGI used to quote one genome as 1x genome not 30x genome. So they are in fact claiming they can make a machine at a throughput similar to HiSeq X.
How's the error rate of Complete Genomics? How does it compare to Illumina machines?
Leave a comment:
-
Originally posted by ymc View Post
Leave a comment:
-
It is always good to have additional options .. specially if the pricing is reasonable.
That said providing field support (applications/software) for new instruments is not trivial but perhaps BGI has the money do that as well.
Leave a comment:
-
In fact, "BGI sequencer" are developed by Complete Genomics........
Leave a comment:
-
new BGI sequencer can sequence 1mil genomes/year
BGI will release two sequencers this year. One big one small. The big one can sequence 1 million genomes per year. No details on the small one. Exact spec will be announced in Q2:
Well, HiSeq X Ten can only do 2400 genomes per machine per year. Assuming this big sequencer is also selling in ten packs, then its throughput is 40x of HiSeq X. Too good to be true???Tags: None
Latest Articles
Collapse
-
by seqadmin
Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...-
Channel: Articles
04-04-2024, 04:25 PM -
-
by seqadmin
Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...-
Channel: Articles
03-22-2024, 06:39 AM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, 04-11-2024, 12:08 PM
|
0 responses
25 views
0 likes
|
Last Post
by seqadmin
04-11-2024, 12:08 PM
|
||
Started by seqadmin, 04-10-2024, 10:19 PM
|
0 responses
29 views
0 likes
|
Last Post
by seqadmin
04-10-2024, 10:19 PM
|
||
Started by seqadmin, 04-10-2024, 09:21 AM
|
0 responses
25 views
0 likes
|
Last Post
by seqadmin
04-10-2024, 09:21 AM
|
||
Started by seqadmin, 04-04-2024, 09:00 AM
|
0 responses
52 views
0 likes
|
Last Post
by seqadmin
04-04-2024, 09:00 AM
|
Leave a comment: